Adam Drapczuk
Vermögen: 61 315 $ am 30.06.2026
Vermögen: 61 315 $ am 30.06.2026
Adam E.
Drapczuk worked at West-Ward Pharmaceutical Corp.
from 2001 to 2011, serving as Finance Director from 2008 to 2011.
From 2011 to 2016, worked at Tris Pharma, Inc. as Finance Director & Controller.
In 2016, held the position of Chief Financial Officer & Vice President-Finance at Inpellis, Inc. Also in 2016, worked as Financial Controller at R-Pharm US LLC until 2020.
From 2021 to 2025, served as Chief Financial & Accounting Officer at NexGel, Inc., continuing in that role through 2026.
Education includes undergraduate studies at Susquehanna University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEXGEL, INC. 1,33 % | 03.06.2026 | 122.385 ( 1,33 % ) | 61 315 $ | 30.06.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| NEXGEL, INC. | Comptroller/Controller/Auditor | 27.04.2026 |
| NEXGEL, INC. | Finanzdirektor/CFO | 31.12.2025 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Comptroller/Controller/Auditor | 01.04.2020 |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Finanzdirektor/CFO | 01.04.2016 |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Finanzdirektor/CFO | 01.02.2016 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Susquehanna University
Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Provides generic prescription medication services | Health Technology |
NexGel, Inc.
NexGel, Inc. Chemicals: SpecialtyProcess Industries Manufactures hydrogel compounds | Process Industries |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen